New Treatments for Achalasia: Novel Ideas, but Are They Ready for Prime Time?
- Joel E. Richter
- … show all 1 hide
Achalasia is a rare disorder (1/100,000 people per year) without any age or gender predilection . Patients typically present with dysphagia for solids and liquids, regurgitation of undigested food, nocturnal coughing, chest pain, and weight loss. These symptoms result from impaired, usually absent, peristalsis and incomplete relaxation of the lower esophageal sphincter (LES) leading to stasis of food in the esophagus and esophageal dilation. Why the enteric esophageal neurons gradually disappear in patients with achalasia remains unknown. Evidence is accumulating that an autoimmune response targeted against these neurons, triggered by an infectious agent, possibly HSV-1, may be involved . The diagnosis is made by a combination of tests including barium esophagram, esophageal manometry, and upper endoscopy.
No treatment for achalasia can restore muscular activity to the denervated esophagus; as a consequence, esophageal aperistalsis is rarely reversed. All treatments are thus direc ...
- Richter JE, Boeckxstaens GE. Management of achalasia: surgery or pneumatic dilation. Gut. 2011;60:869–876. CrossRef
- Facco M, Brun P, Baesso I, et al. T cells in the myenteric plexus of achalasia patients showed a skewed TCR repertoire and react to HSV-1 antigens. Am J Gastroenterol. 2008;103:1598–1609. CrossRef
- Richter JE. Update on the management of achalasia: balloons, surgery and drugs. Expert Rev Gastroenterol Hepatol. 2008;2:435–445. CrossRef
- Eckardt VF, Stauf B, Bernhard G. Chest pain in achalasia: patient characteristics and clinical course. Gastroenterology. 1999;116:1300–1304. CrossRef
- Vela MF, Richter JE, Washberger D, et al. Complexities of managing achalasia at a tertiary referral center: use of pneumatic dilation, Heller myotomy and botulinum toxin injection. Am J Gastroenterol. 2004;99:1029–1036. CrossRef
- Hoogerwerf W, Pasricha PJ. Pharmacologic therapy in treating achalasia. Gastrointest Endosc Clin North Am. 2001;11:311–323.
- Pasricha PJ, Rai R, Ravich WJ, et al. Botulinum toxin for achalasia: long-term outcome and redictors of response. Gastroenterology. 1996;110:1410–1415. CrossRef
- Kadakia SC, Wong RK. Graded pneumatic dilation using Rigiflex achalasia dilators in patients with primary esophageal achalasia. Am J Gastroenterol. 1993;103:1732–1738.
- Vela MF, Ricther JE, Khandwala E, et al. The long-term efficacy of pneumatic dilation and Heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol. 2006;4:580–587. CrossRef
- Katzka DA, Castell DO. Review article: an analysis of the efficacy, perforation rates and methods used in pneumatic dilation for achalasia. Alim Pharmacol Therap. 2011;34:832–839. CrossRef
- Zerbid F, Thetiot V, Ricky F, et al. Repeated pneumatic dilations as long-term maintenance therapy for esophageal achalasia. Am J Gastroenterol. 2006;101:692–697. CrossRef
- Vantrappen G, Helemans J, Deloof W, et al. Treatment of achalasia with pneumatic dilation. Gut. 1971;12:268–275. CrossRef
- Vaezi MF, Baker MF, Achkar E, Richter JE. Timed barium esophagram: better predictor of long-term success after pneumatic dilation than symptom assessment. Gut. 2002;50:765–770. CrossRef
- Pandolfino JE, Kwiatek MA, Nealis T, et al. Achalasia: it’s not all one disease—subclassification by high-resolution manometry. Gastroenterology. 2008;135:1383–1391. CrossRef
- Oelschager BK, Chang L, Pellegrini CA. Improved outcomes after extended gastric myotomy in achalasia. Arch Surg. 2003;139:490–495. CrossRef
- Richards W, Torquati A, Holzman M, et al. Heller myotomy vs Heller myotomy with Dor fundoplication for achalasia: a prospective randomized double-blind clinical trial. Ann Surg. 2004;240:405–415. CrossRef
- Campos GM, Vittinghoff E, Rabi C, et al. Endoscopic and surgical treatment for achalasia. A systemic review and metal-analysis. Ann Surg. 2009;249:45–57. CrossRef
- Sharp KW, Khaitan L, Scholz S, et al. 100 consecutive minimally invasive Heller myotomies: lessons learned. Ann Surg. 2002;235:631–639. CrossRef
- Boeckxstaens GE, Annese V, Bruley des Varannes S, et al. Pneumatic dilation vs laparoscopic Heller myotomy for idiopathic achalasia. N Eng J Med. 2011;364:1807–1816. CrossRef
- Inoue H, Minami H, Kobayashi Y, et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 2010;42:265–271. CrossRef
- Renteln D, Inoue H, Minami H, et al. Peroral endoscopic myotomy for the treatment of achalasia: a prospective single center study. Am J Gastroenterol. 2012;107:411–417. CrossRef
- Stavropoulos S, Brathwaite C, Halwon B, et al. POEM: effective NOTES accessible to the gastroenterologist, 3-year experience at US Center. Am J Gastroenterol. 2012;107(Suppl):S1909.
- Cheny YS, Ma F, Li YD, et al. Temporary self-expanding metallic stents for achalasia: a prospective study with long-term follow-up. World J Gastroenterol. 2010;16:5111–5117. CrossRef
- Moreto M, Ojembarrena E, Bareuren A, Casedo I. Treatment of achalasia by injection of scerlosant substances: a long term report. Dig Dis Sci. 2012. (Epub ahead of print). doi:10.1007/s10620-012-2476-x.
- Richter JE. The diagnosis and misdiagnosis of achalasia: it does not have to be so difficult. Clin Gastroenterol Hep. 2011;9:1010–1011. CrossRef
- New Treatments for Achalasia: Novel Ideas, but Are They Ready for Prime Time?
Digestive Diseases and Sciences
Volume 58, Issue 3 , pp 596-599
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Industry Sectors
- Joel E. Richter (1)
- Author Affiliations
- 1. Division of Digestive Diseases and Nutrition, Department of Internal Medicine, Center for Esophageal and Swallowing Disorders, University of South Florida College of Medicine, 12901 Bruce B. Downs Blvd., MDC 72, Tampa, FL, 33612, USA